because the business model of MDR has not worked and has shown virtually no organic growth at all. You should think if the major acquisition as a life saver for this sad business. Hopefully they will work it out. Am guessing this is why Josh has been selling down his holding.
- Forums
- ASX - By Stock
- Ann: MDR Quarterly Report & Appendix 4C
MDR
medadvisor limited
Add to My Watchlist
2.50%
!
8.2¢

because the business model of MDR has not worked and has shown...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.2¢ |
Change
0.002(2.50%) |
Mkt cap ! $49.98M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 7.8¢ | $35.28K | 441.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 120244 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 4243 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 136299 | 0.080 |
3 | 58609 | 0.078 |
1 | 120000 | 0.077 |
3 | 232747 | 0.076 |
2 | 59833 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 100000 | 1 |
0.083 | 4243 | 1 |
0.084 | 110000 | 2 |
0.088 | 1944 | 1 |
0.090 | 42500 | 2 |
Last trade - 15.32pm 18/06/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online